An interventional study of in vitro matuartion of oocytes in Infertility and Polycystic Ovaries, sponsored by Assaf-Harofeh Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 39 Years. Per ClinicalTrials.gov, last updated 2008-03-10.
Sponsored by Assaf-Harofeh Medical Center · Not applicable, Interventional, and Treatment
In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.
944 studies on the registry are indexed under Polycystic Ovary Syndrome; 174 are open to participants now.
This study's planned enrollment of 30 is below the median of 70 across 685 interventional studies indexed under Polycystic Ovary Syndrome.
Browse Polycystic Ovary Syndrome studies →Assaf-Harofeh Medical Center is the lead sponsor of 258 studies on the registry; 40 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
Procedure: in vitro matuartion of oocytes
in vitro maturation of (immature) oocytes
maturation rate,
Time frame: 18 months
Fertilization rate, pregnancy rate
Time frame: 18 months
This study is status unknown, as verified in Mar 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assaf-Harofeh Medical Center